Pharmaceutical, Biotech Stocks Stabilize
This is a news story, published by Yahoo Finance, that relates primarily to The Motley Fool news.
stocks trading & speculation news
For more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
pharmaceuticals. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Catalyst Pharmaceuticals news, pharma industry news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
pharmaceutical exportsThe Motley Fool
•Business
Business & Economics
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday

71% Informative
Catalyst Pharmaceuticals' 1.5% drop was mild compared to the S&P 500's 4.8% tumble.
Some stocks in biotech and pharmaceuticals were actually in positive territory.
The administration is gearing up to roll out a set of tariffs specifically targeting pharmaceutical exports soon.
The Motley Fool has positions in and recommends Amgen and Veeva Systems . The Motley Fool recommends AstraZeneca Plc . The Motley Fool has a disclosure policy. Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday was originally published by The Motley Fool .
VR Score
68
Informative language
66
Neutral language
21
Article tone
semi-formal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links
Small business owner?